NASDAQ: CGTXCognition Therapeutics Inc Stock Ownership - Who owns Cognition Therapeutics?
Insider buying vs selling
Have Cognition Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John Brendan Doyle | Chief Financial Officer | 2025-05-01 | 9,692 | $0.45 | $4.33kSell |
| Anthony Caggiano | Chief Medical Officer | 2025-02-15 | 5,296 | $0.59 | $3.12kSell |
| John Brendan Doyle | Chief Financial Officer | 2025-02-15 | 1,723 | $0.59 | $1.02kSell |
| Lisa Ricciardi | CEO President | 2025-02-15 | 6,619 | $0.59 | $3.91kSell |
| Anthony Caggiano | Chief Medical Officer | 2025-02-03 | 12,779 | $0.67 | $8.51kSell |
| Lisa Ricciardi | CEO President | 2025-02-03 | 28,960 | $0.67 | $19.29kSell |
| Lisa Ricciardi | CEO President | 2025-01-31 | 38,851 | $0.77 | $29.99kBuy |
CGTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CGTX insiders and whales buy or sell their stock.
CGTX Shareholders
What type of owners hold Cognition Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Aaron Gl Fletcher | 16.57% | 10,269,218 | $7.19M | Insider |
| Leslie W. Kreis | 10.25% | 6,356,377 | $4.45M | Insider |
| Bios Capital Management LP | 9.68% | 6,000,000 | $4.20M | Institution |
| Bios Memory Spv I LP | 6.31% | 3,912,841 | $2.74M | Insider |
| Ogden Cap Associates LLC | 3.57% | 2,210,377 | $1.55M | Insider |
| Vanguard Group Inc | 2.00% | 1,239,167 | $867.42k | Institution |
| Acadian Asset Management LLC | 1.63% | 1,007,586 | $705.31k | Institution |
| Lisa Ricciardi | 1.49% | 925,917 | $648.14k | Insider |
| Sigma Planning Corp | 0.98% | 608,390 | $425.87k | Institution |
| Bios Clinical Opportunity Fund LP | 0.81% | 500,095 | $350.07k | Insider |
CGTX vs Biotech Stocks
Cognition Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.